Corrigendum to Post Ballot Notice

SHUKRA PHARMACEUTICALS LTD. September 22, 2026 BSE Limited Corporate Relations Department Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai —400001 Scrip Code: 524632 Sub: Submission of Corrigendum to the Postal Ballot Notice dated August 22, 2026 Dear Sir/ Madam, Pursuant to Regulation 30 and Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith a copy of the Corrigendum to the Postal Ballot Notice dated August 22, 2026 ("Notice"). The Notice was previously dispatched to the shareholders on August 27, 2026, for seeking approval regarding the alteration of the Main Object Clause of the Memorandum of Association (MOA) and the change of name of the Company to "SHUKRA MEDTECH LIMITED". This Corrigendum is being issued to substitute the original Independent Auditor's Certificate (Annexure-A) with a Revised Auditor's Certificate dated September 16, 2026, issued by the Statutory Auditors, M/s Shah Sanghvi & Associates, Chartered Accountants. This update provides detailed numerical parameters to strictly align with the layout mandated under Regulation 45 of the SEBI (LODR) Regulations, 2015, following observations from BSE Limited. The Corrigendum is being dispatched electronically to all eligible members and is also available on the website of the Company. All other contents, details, and the active remote e-voting timelines of the original Notice remain unchanged. We request you to kindly take the same on your records and disseminate it on your website for the information of investors. Thanking you, Yours faithfully, For Shukra Pharmaceuticals Limited Dakshesh Shah Chairman & Managing Director DIN: 00561666 CIN : L24231GJ1993PLC019079 Regd. Office : 3rd Floor, "VEER HOUSE" Opp. WIAA Office, Judges Bunglow Road, Bodakdev, Ahmedabad-380 054. Factory Add. : 795, Rakanpur, Sola-Santej Road, Ta. Kalol, Dist. Gandhinagar-382721, Gujarat, India, Ph. : 02764-286317 SHUKRA PHARMACEUTICALS LTD. CORRIGENDUM TO THE POST Dear Members, This is in reference to the Postal Ballot Notice dated August22,2026 ("Notice"), issued by Shukra Pharmaceuticals Limited ("the Company") for seeking the approval of members via remote e-voting for: 1,. Alteration of the Main Object Clause of the Memorandum of Association (MOA). Change of name of the company from "sHUKRA PHARMACEUTICALS LIMITED,' to "SHUKRA MEDTECH LIMITED" and consequent amendments to the Memorandum and Articles of Association (AOA). The Notice was dispatched to the eligible shareholders of the Company on August 27,2026. This Corrigendum is being issued to bring to the attention of all shareholders certain updates/revisions regarding Annexure-A (the lndependent Auditor's Cer[ificate) attached to the Explanatory Statement of the said Notice (page no. 14 to 15 of the Postal Ballot notice dated August22,2026). 1. REVISION OF THE CHARTERED ACCOUNTANT CERTIFICATE (ANNEXURE-A) Pursuant to the observations and directions received from the BSE Limited (BSE) during the application for in-principle approval for the change of name, the Company has obtained a Revised Chartered Accountant Certificate from its statutory Auditors, M/s shah sanghvi & Associates, Chartered Accountants. The original certificate required further disclosure of numerical parameters and figures to strictly align with the format under Regulation 45 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Accordingly, the existing lndependent Auditor's Certificate issued by M/s Shah Sanghvi & Associates, Chartered Accountants, dated August 27,2026 (attached as Annexure-A on page 16-1g ofthe Notice), stands replaced and substituted in its entirety with the Revised Auditor's Certificate dated September 1_6,201-6 All references to the Chartered Accountant's Certificate under ltem No. 2 of the Explanatory Statement (Page L6-18) shall be construed as references to the Auditor's Revised Certificate. The Revised CA Certificate hos been uploaded alongside this Corrigendum ond is avoiloble on the website of the Compony ot www.shukrapharmaceuticals.com ond on the Stock Exchange website(s). 2. UPDATE ON REMOTE E-VOTING FOR SHAREHOLDERS The remote e-voting period commenced on Friday, August 28,2026 (09:00 A.M. IST) and concludes on Saturday, September 26,2026 (05:00 P.M. tST). Since the remote e-voting window is already active, it is possible that some shareholders have already cast their votes based on the previous notice layout. To ensure absolute transparency and give shareholders a fair opportunity to review the newly detailed figures in the revised certificate, the following system will apply: CIN : t24231GJ1993PtC019079 Regd. Office : 3rd Floor, "VEER HOUSE" Opp. WIAA Office, Judges Bunglow Road, Bodakdev, Ahmedabad - 380 054. Factory Add. : 795, Rakanpur, Sola-Santej Road, Ta. Kalol, Dist. Gandhinagar -382721, Gujarat, lndia, Ph. :02764-2863L7 SHUKRA PHARMACEUTICALS LTD. ((( 321 ))) pe Fc ls f rlo oh e ear ra vcr isr i t s og re h ho ueh a an sno r lrid e yc eld u h hve rm o o eor l ld s t de ea e w rr r w r de sh o ei lp p lo dwse t us vr hh pm oa ot eo tiv t r t hse e v we a oda d v t ll ee e ltr o e ra a a al g mlo nd ra eg dy ai n a ii nc c n da do t y vo num cr vt li e ip nh o dlgl e t oe e ut tN d ne h t S d e at D h wnt aL eh idc le le t v i d- v o bir v e et o e oe .v onc- t ov i a ronn no s t: n;t t'i ; wpfn "; orag iw e s " vi h ap n, i oo r ti fua o oo inn swr ld cy, t lh co t o baha n yns et t gh tt i hhrt ee h ee se t ui shNis br ceSs s rvu uD ieo ra tLq it nvn e u p ioc ze oae etn rg e rttao .a ,/ ri lnf a t. h. tt e eh s ii rs t GENERALINSTRUCTIONS: nT 2 oh 0 ti 2s e 6 sc 'o oar fr n i tg d h e etn h od e ru i gm E inx aps rlh ao pnu oal sd t to arb ry e B sr ate a ra otd e t mi Nn e oc n to it cn eaju n rn enc meti x ao e in nd w eth nit e th irr eeth rt yoe . o A nri cg il in o aa nthr e ep r do .s ct oar n tB ea ni tl so ,t tN eo rmtic se , d reat se od r uA tiu og nu ss , t a 2 n2 d, This corrigendum along with th *e 't ^R evised cA certificate is being sent erectronicaly to a, members :'ffiili,ir?:il?,':fftff:: the Depositories/RrA and is atso avaitabte on the website or the By Order of the Board For Shukra pharmaceuticals Limited Dakshesh Shah Chairman & Managing Director DIN:00561666 Date: Septe mber 22,2026 Place: Ahmedabad Encl: as above CIN : 124231GJ1993P1C019079 Regd. Office : 3rd Floor, "VEER HOUSE" Opp. WIAA Office, Judges Bunglow Road, Bodakdev, Ahmedabad-38O 054. FactoryAdd. : 795, Rakanpur; Sola-Santej Road, Ta. Kalol, Dist. Gandhinagar-382721, Gujarat, lndia, Ph.:O2764-2863L7 E m a i I : j.nfp @ S h"q k f"a.p--f .a 1 m q_9 e uti ca I s. co m Website : www.sh ukra pha rmaceuticals .com